Hologic Historical Income Statement

HOLX Stock

USD 79.44 0.44 0.56%

Historical analysis of Hologic income statement accounts such as Total Revenue of 4.2 B or Gross Profit of 2.3 B can show how well Hologic performed in making a profits. Evaluating Hologic income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Hologic's future profits or losses.

Cash Flow Balance Sheet Income Statement

Oil Shock

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Hologic latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Hologic is a good buy for the upcoming year.

Net Income Gross Profit

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hologic. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

For more information on how to buy Hologic Stock please use our How to Invest in Hologic guide.

About Hologic Income Statement Analysis

Hologic Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Hologic shareholders. The income statement also shows Hologic investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Hologic Income Statement Chart

At this time, Hologic's Net Income is fairly stable compared to the past year. Research Development is likely to rise to about 286.4 M in 2024, whereas Interest Expense is likely to drop slightly above 74.8 M in 2024.

Interest Expense Total Revenue Gross Profit Other Operating Expenses Operating Income Net Income From Continuing Ops

Interest Expense

The cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit.

Total Revenue

Total revenue comprises all receipts Hologic generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Hologic minus its cost of goods sold. It is profit before Hologic operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Hologic. It is also known as Hologic overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Operating Income

Operating Income is the amount of profit realized from Hologic operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Hologic is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.

Most accounts from Hologic's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Hologic current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hologic. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

For more information on how to buy Hologic Stock please use our How to Invest in Hologic guide.At this time, Hologic's Net Income is fairly stable compared to the past year. Research Development is likely to rise to about 286.4 M in 2024, whereas Interest Expense is likely to drop slightly above 74.8 M in 2024.

	2021	2022	2023	2024 (projected)
Interest Expense	95.1M	111.1M	122.1M	74.8M
Depreciation And Amortization	430.1M	323.4M	309M	324.5M

Interest Expense Depreciation And Amortization

Hologic income statement Correlations

	Depreciation And Amortization	Interest Expense	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Research Development	Selling General Administrative	Selling And Marketing Expenses	Net Income From Continuing Ops	Non Recurring	Non Operating Income Net Other	Tax Provision	Interest Income	Net Interest Income	Reconciled Depreciation	Minority Interest	Extraordinary Items
Depreciation And Amortization		0.03	0.62	0.55	0.66	0.45	0.39	0.58	0.63	0.68	0.42	0.22	0.45	0.18	0.67	0.66	0.72	0.64	-0.34	-0.07	0.09	-0.77	0.13	-0.01	-0.14	-0.32
Interest Expense	0.03		-0.04	-0.15	0.14	-0.44	-0.29	-0.25	0.15	0.13	-0.51	-0.42	-0.56	-0.17	0.19	0.0	0.09	-0.05	-0.76	-0.39	-0.19	0.24	-0.39	0.33	0.27	0.43
Total Revenue	0.62	-0.04		0.97	0.91	0.71	0.85	0.9	0.89	0.92	0.69	0.07	0.7	0.43	0.91	0.95	0.86	0.88	-0.52	0.29	0.43	-0.6	0.59	-0.47	-0.38	-0.75
Gross Profit	0.55	-0.15	0.97		0.78	0.81	0.95	0.97	0.74	0.81	0.8	0.11	0.81	0.51	0.8	0.87	0.75	0.89	-0.39	0.22	0.5	-0.58	0.53	-0.45	-0.39	-0.7
Other Operating Expenses	0.66	0.14	0.91	0.78		0.46	0.56	0.65	0.99	0.99	0.44	0.03	0.45	0.25	0.97	0.96	0.91	0.76	-0.66	0.36	0.25	-0.55	0.59	-0.45	-0.31	-0.69
Operating Income	0.45	-0.44	0.71	0.81	0.46		0.85	0.86	0.42	0.5	0.99	0.61	0.97	0.76	0.51	0.6	0.48	0.84	0.04	0.21	0.72	-0.54	0.38	-0.37	-0.33	-0.57
Ebit	0.39	-0.29	0.85	0.95	0.56	0.85		0.98	0.52	0.6	0.85	0.12	0.85	0.56	0.6	0.69	0.56	0.81	-0.19	0.16	0.55	-0.49	0.46	-0.4	-0.38	-0.64
Ebitda	0.58	-0.25	0.9	0.97	0.65	0.86	0.98		0.61	0.69	0.85	0.16	0.86	0.53	0.69	0.76	0.66	0.86	-0.24	0.12	0.51	-0.61	0.44	-0.36	-0.37	-0.64
Cost Of Revenue	0.63	0.15	0.89	0.74	0.99	0.42	0.52	0.61		0.96	0.4	0.0	0.41	0.22	0.94	0.93	0.9	0.71	-0.65	0.36	0.23	-0.54	0.58	-0.43	-0.3	-0.72
Total Operating Expenses	0.68	0.13	0.92	0.81	0.99	0.5	0.6	0.69	0.96		0.49	0.07	0.5	0.27	0.98	0.98	0.9	0.8	-0.66	0.35	0.28	-0.57	0.6	-0.46	-0.32	-0.64
Income Before Tax	0.42	-0.51	0.69	0.8	0.44	0.99	0.85	0.85	0.4	0.49		0.62	0.98	0.74	0.49	0.59	0.47	0.81	0.1	0.28	0.72	-0.53	0.44	-0.42	-0.36	-0.6
Total Other Income Expense Net	0.22	-0.42	0.07	0.11	0.03	0.61	0.12	0.16	0.0	0.07	0.62		0.56	0.62	0.09	0.12	0.07	0.37	0.36	0.29	0.59	-0.25	0.15	-0.21	-0.1	-0.12
Net Income	0.45	-0.56	0.7	0.81	0.45	0.97	0.85	0.86	0.41	0.5	0.98	0.56		0.6	0.48	0.61	0.48	0.82	0.13	0.28	0.59	-0.58	0.46	-0.45	-0.47	-0.65
Income Tax Expense	0.18	-0.17	0.43	0.51	0.25	0.76	0.56	0.53	0.22	0.27	0.74	0.62	0.6		0.34	0.31	0.28	0.53	-0.03	0.19	0.97	-0.23	0.21	-0.19	0.11	-0.24
Research Development	0.67	0.19	0.91	0.8	0.97	0.51	0.6	0.69	0.94	0.98	0.49	0.09	0.48	0.34		0.94	0.86	0.8	-0.67	0.34	0.35	-0.51	0.6	-0.48	-0.3	-0.61
Selling General Administrative	0.66	0.0	0.95	0.87	0.96	0.6	0.69	0.76	0.93	0.98	0.59	0.12	0.61	0.31	0.94		0.89	0.84	-0.56	0.35	0.32	-0.6	0.64	-0.51	-0.39	-0.7
Selling And Marketing Expenses	0.72	0.09	0.86	0.75	0.91	0.48	0.56	0.66	0.9	0.9	0.47	0.07	0.48	0.28	0.86	0.89		0.75	-0.56	0.29	0.25	-0.69	0.45	-0.32	-0.29	-0.62
Net Income From Continuing Ops	0.64	-0.05	0.88	0.89	0.76	0.84	0.81	0.86	0.71	0.8	0.81	0.37	0.82	0.53	0.8	0.84	0.75		-0.43	0.19	0.48	-0.62	0.38	-0.35	-0.41	-0.55
Non Recurring	-0.34	-0.76	-0.52	-0.39	-0.66	0.04	-0.19	-0.24	-0.65	-0.66	0.1	0.36	0.13	-0.03	-0.67	-0.56	-0.56	-0.43		0.0	-0.03	0.16	-0.07	0.05	0.06	0.09
Non Operating Income Net Other	-0.07	-0.39	0.29	0.22	0.36	0.21	0.16	0.12	0.36	0.35	0.28	0.29	0.28	0.19	0.34	0.35	0.29	0.19	0.0		0.29	-0.24	0.67	-0.62	-0.41	-0.56
Tax Provision	0.09	-0.19	0.43	0.5	0.25	0.72	0.55	0.51	0.23	0.28	0.72	0.59	0.59	0.97	0.35	0.32	0.25	0.48	-0.03	0.29		-0.15	0.34	-0.33	0.09	-0.28
Interest Income	-0.77	0.24	-0.6	-0.58	-0.55	-0.54	-0.49	-0.61	-0.54	-0.57	-0.53	-0.25	-0.58	-0.23	-0.51	-0.6	-0.69	-0.62	0.16	-0.24	-0.15		-0.1	0.0	0.28	0.43
Net Interest Income	0.13	-0.39	0.59	0.53	0.59	0.38	0.46	0.44	0.58	0.6	0.44	0.15	0.46	0.21	0.6	0.64	0.45	0.38	-0.07	0.67	0.34	-0.1		-0.93	-0.45	-0.76
Reconciled Depreciation	-0.01	0.33	-0.47	-0.45	-0.45	-0.37	-0.4	-0.36	-0.43	-0.46	-0.42	-0.21	-0.45	-0.19	-0.48	-0.51	-0.32	-0.35	0.05	-0.62	-0.33	0.0	-0.93		0.59	0.7
Minority Interest	-0.14	0.27	-0.38	-0.39	-0.31	-0.33	-0.38	-0.37	-0.3	-0.32	-0.36	-0.1	-0.47	0.11	-0.3	-0.39	-0.29	-0.41	0.06	-0.41	0.09	0.28	-0.45	0.59		0.62
Extraordinary Items	-0.32	0.43	-0.75	-0.7	-0.69	-0.57	-0.64	-0.64	-0.72	-0.64	-0.6	-0.12	-0.65	-0.24	-0.61	-0.7	-0.62	-0.55	0.09	-0.56	-0.28	0.43	-0.76	0.7	0.62

Click cells to compare fundamentals

Hologic Account Relationship Matchups

Hologic income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Depreciation And Amortization	376M	406.9M	430.1M	323.4M	309M	324.5M
Interest Expense	116.5M	93.6M	95.1M	111.1M	122.1M	74.8M
Total Revenue	3.8B	5.6B	4.9B	4.0B	4.0B	4.2B
Gross Profit	2.2B	3.8B	3.0B	2.1B	2.2B	2.3B
Other Operating Expenses	2.7B	3.1B	3.2B	3.3B	3.1B	3.3B
Operating Income	1.1B	2.5B	1.6B	668.4M	882.6M	926.7M
Ebit	1.1B	2.5B	1.7B	787.2M	987.2M	1.0B
Ebitda	1.5B	2.9B	2.1B	1.1B	1.3B	1.4B
Cost Of Revenue	1.5B	1.8B	1.9B	2.0B	1.8B	1.9B
Total Operating Expenses	1.1B	1.3B	1.4B	1.3B	1.3B	1.4B
Income Before Tax	1.0B	2.4B	1.6B	676.1M	865.1M	908.4M
Total Other Income Expense Net	(103.1M)	(119.2M)	(52M)	7.7M	(17.5M)	(18.4M)
Net Income	1.1B	1.9B	1.3B	456M	789.5M	829.0M
Income Tax Expense	(108.6M)	491.4M	286.2M	220.1M	75.6M	48.9M
Research Development	222.5M	276.3M	283.4M	294.3M	272.8M	286.4M
Selling General Administrative	356M	433.2M	407.7M	392.4M	409.4M	429.9M
Net Income Applicable To Common Shares	1.1B	1.9B	1.3B	456M	524.4M	550.6M
Selling And Marketing Expenses	484.6M	561.2M	630.3M	595.2M	585.4M	375.5M
Net Income From Continuing Ops	1.1B	1.9B	1.3B	456M	524.4M	550.6M
Tax Provision	(108.6M)	491.4M	286.2M	220.1M	253.1M	138.5M
Interest Income	4.3M	1.4M	12.9M	120.5M	108.5M	113.9M
Net Interest Income	(112.2M)	(92.2M)	(82.2M)	9.4M	10.8M	11.4M
Reconciled Depreciation	376M	406.9M	430.1M	323.4M	291.1M	334.7M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ESRT	Empire State Realty
C	Citigroup
C	Citigroup

Additional Tools for Hologic Stock Analysis

When running Hologic's price analysis, check to measure Hologic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hologic is operating at the current time. Most of Hologic's value examination focuses on studying past and present price action to predict the probability of Hologic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hologic's price. Additionally, you may evaluate how the addition of Hologic to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Hologic Historical Income Statement

About Hologic Income Statement Analysis

Hologic Income Statement Chart

Interest Expense

Total Revenue

Gross Profit

Other Operating Expenses

Operating Income

Hologic income statement Correlations

Hologic Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Hologic income statement Accounts

Also Currently Popular

Additional Tools for Hologic Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cost Of Revenue	+ 0.99	Other Operating Expenses
Total Operating Expenses	+ 0.99	Other Operating Expenses
Income Before Tax	+ 0.99	Operating Income
Ebitda	+ 0.98	Ebit
Research Development	+ 0.98	Total Operating Expenses
Selling General Administrative	+ 0.98	Total Operating Expenses

Reconciled Depreciation	- 0.93	Net Interest Income
Interest Income	- 0.77	Depreciation And Amortization
Extraordinary Items	- 0.76	Net Interest Income
Non Recurring	- 0.76	Interest Expense
Extraordinary Items	- 0.75	Total Revenue
Extraordinary Items	- 0.72	Cost Of Revenue